Retatrutide Phase 2 Trial Targets Obesity Without Diabetes | Retatrutide News

A Phase 2 trial is recruiting to study retatrutide in obese adults without diabetes. This trial assesses efficacy and safety in managing obesity.
Clinical Trials · October 11, 2026